Zobrazeno 1 - 10
of 56
pro vyhledávání: '"smf Pluijm"'
Autor:
smf Pluijm, m Visser, mte Puts, mg Dik, bwm Schalk, nm van Schoor, la Schaap, rj Bosscher, djh Deeg
Publikováno v:
Tijdschrift voor Gerontologie en Geriatrie, Iss 6 (2024)
Ongezonde leefstijl en lichamelijke achteruitgang : samenvatting Het doel van deze studie was de samenhang te onderzoeken tussen ongezonde leefstijl op jonge, middelbare, en/of oudere leeftijd en lichamelijke achteruitgang op oudere leeftijd en tusse
Externí odkaz:
https://doaj.org/article/5cd0c7a614c04003ba878e33efe98424
Publikováno v:
Pediatric bloodcancer. 62(2)
Publikováno v:
Pediatric Rheumatology Online Journal, Vol 6, Iss Suppl 1, p P15 (2008)
Pediatric Rheumatology Online Journal
Pediatric Rheumatology Online Journal
Methods Genotypes were determined in an observational cohort of 183 JIA patients that had been systematically followed at 3 months intervals. The following SNPs were determined: methylenetetrahydrofolate reductase (MTHFR) 677C>T and 1298A>C, methioni
Autor:
Bouwman E; Radboud University Medical Center, Nijmegen, The Netherlands., Penson A; Radboud University Medical Center, Nijmegen, The Netherlands., de Valk M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van den Oever SR; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van der Pal HJH; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; PanCare, Bussum, The Netherlands., van Dulmen-den Broeder E; Amsterdam University Medical Center, Amsterdam, The Netherlands., Blijlevens NMA; Radboud University Medical Center, Nijmegen, The Netherlands., Bresters D; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Feijen EAM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, The Netherlands.; Utrecht University and Utrecht Medical Center, Utrecht, The Netherlands., van der Heiden-van der Loo M; Dutch Childhood Oncology Group-Late Effects After Childhood Cancer (LATER) Registry, Utrecht, The Netherlands., Michel G; Faculty of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland., Ronckers CM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Division of Childhood Cancer Epidemiology, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Teepen JC; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Tissing WJE; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; University Medical Center Groningen, Groningen, The Netherlands., Versluys BAB; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Kremer LCM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Utrecht University and Utrecht Medical Center, Utrecht, The Netherlands.; Amsterdam University Medical Center, Amsterdam, The Netherlands., Pluijm SMF; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Loonen JJ; Radboud University Medical Center, Nijmegen, The Netherlands.
Publikováno v:
Cancer [Cancer] 2024 Aug 15; Vol. 130 (16), pp. 2856-2872. Date of Electronic Publication: 2024 Apr 25.
Autor:
Houtman BM; Radboudumc Center of Expertise for Cancer Survivorship, Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.; Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Walraven I; Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., Kapusta L; Department of Pediatric Cardiology, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Pediatrics, Pediatric Cardiology Unit, Tel Aviv Sourasky Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel., Teske AJ; Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands., van Dulmen-den Broeder E; Department of Pediatric Oncology, Amsterdam UMC, VU University, Amsterdam, The Netherlands., Tissing WJE; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology, Erasmus Medical Center, Sophia Children's Hospital, Rotterdam, The Netherlands.; Wilhelmina Children's Hospital, University Medical Center, Utrecht, The Netherlands., Versluys ABB; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Bresters D; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van der Heiden-van der Loo M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Ronckers C; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Division of Childhood Cancer Epidemiology, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Kok WEM; Department of Cardiology Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., van der Pal HJH; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Pluijm SMF; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Janssens GO; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., Blijlevens NMA; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Kremer LCM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Wilhelmina Children's Hospital, University Medical Center, Utrecht, The Netherlands.; Department of Pediatric Oncology, Emma Children's Hospital, University of Amsterdam, Amsterdam, The Netherlands., Loonen JJ; Radboudumc Center of Expertise for Cancer Survivorship, Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Feijen EAML; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Nov; Vol. 71 (11), pp. e31251. Date of Electronic Publication: 2024 Aug 12.
Autor:
de Beijer IAE; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Bouwman E; Department of Hematology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands., Mulder RL; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Steensma P; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Brown MC; Population Health Sciences Institute, Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK., Araújo-Soares V; Center for Preventive Medicine and Digital Health, Department for Prevention, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Balcerek M; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany., Bardi E; St Anna Children's Hospital, Vienna, Austria.; Department of Pediatric and Adolescent Medicine, Kepler University Clinic, Linz, Austria., Falck Winther J; Childhood Cancer Research Group, Danish Cancer Society Research Center, Copenhagen, Denmark.; Department of Clinical Medicine and Faculty of Health, Aarhus Universitet, Aarhus, Denmark., Frederiksen LE; Childhood Cancer Research Group, Danish Cancer Society Research Center, Copenhagen, Denmark., van Gorp M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Oberti S; DOPO clinic, Department of Hematology/Oncology, IRCCS Istituto Giannina Gaslini, Genoa, Italy., van Kalsbeek RJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Kepak T; International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic., Kepakova K; International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic., Gsell H; Childhood Cancer International Europe, Vienna, Austria., Kienesberger A; Childhood Cancer International Europe, Vienna, Austria., van Litsenburg R; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Mader L; Childhood Cancer Research Group, Danish Cancer Society Research Center, Copenhagen, Denmark.; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland., Michel G; Faculty of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland., Muraca M; DOPO clinic, Department of Hematology/Oncology, IRCCS Istituto Giannina Gaslini, Genoa, Italy., van den Oever SR; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van der Pal HJH; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; PanCare, Bussum, The Netherlands., Roser K; Faculty of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland., Skinner R; Great North Children's Hospital, Royal Victoria Infirmary, Newcastle Upon Tyne, UK.; Translational and Clinical Research Institute, Wolfson Childhood Cancer Research Centre, Newcastle Upon Tyne, UK., Stolman I; Department of Hematology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands., Uyttebroeck A; Department of Oncology, Paediatric Oncology, KU Leuven, Department of Paediatric Haematology and Oncology, University Hospitals Leuven, Leuven, Belgium., Kremer LCM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Paediatrics, Emma Children's Hospital, Amsterdam, The Netherlands.; Faculty of Medicine, Utrecht University and Utrecht Medical Center, Utrecht, The Netherlands., Loonen J; Department of Hematology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands., van Dalen EC; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Pluijm SMF; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Publikováno v:
Cancer medicine [Cancer Med] 2024 Jun; Vol. 13 (12), pp. e7361.
Autor:
Penson A; Center of Expertise for Cancer Survivorship, Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Walraven I; Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., Bronkhorst E; Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., Grootenhuis MA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Maurice-Stam H; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Loo MVH; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Tissing WJE; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology/Hematology, Beatrix Children's Hospital/University of Groningen/University Medical Center Groningen, Groningen, The Netherlands., van der Pal HJH; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., de Vries ACH; Department of Pediatric Oncology, Erasmus Medical Center, Rotterdam, The Netherlands., Bresters D; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Ronckers CM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Division of Childhood Cancer Epidemiology, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University, Mainz, Germany., van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology, Erasmus Medical Center, Rotterdam, The Netherlands., Neggers S; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Medicine, section Endocrinology, Erasmus Medical Center, Rotterdam, The Netherlands., Versluys BAB; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Louwerens M; Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands., Pluijm SMF; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Blijlevens N; Center of Expertise for Cancer Survivorship, Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., van Dulmen-den Broeder E; Department of Pediatric Oncology/Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Kremer LCM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department Pediatric Oncology, Emma Children's Hospital, University of Amsterdam, Amsterdam, The Netherlands., Knoop H; Department of Medical Psychology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands., Loonen J; Center of Expertise for Cancer Survivorship, Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Jun; Vol. 71 (6), pp. e30951. Date of Electronic Publication: 2024 Mar 31.
Autor:
van den Oever SR; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands. s.r.vandenoever-2@prinsesmaximacentrum.nl., de Beijer IAE; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands., Kremer LCM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; University Medical Center Utrecht, Wilhelmina Children's Hospital, Utrecht, The Netherlands.; Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Alfes M; CCI Europe, Vienna, Austria., Balaguer J; Hospital Universitario y Politécnico La Fe, Valencia, Spain., Bardi E; St. Anna Children's Hospital, Vienna, Austria.; Department of Paediatrics and Adolescent Medicine, Johannes Kepler University Linz, Kepler University Hospital, Linz, Austria., Nieto AC; Hospital Universitario y Politécnico La Fe, Valencia, Spain., Cangioli G; HL7 Europe, Brussels, Belgium., Charalambous E; HL7 Europe, Brussels, Belgium., Chronaki C; HL7 Europe, Brussels, Belgium., Costa T; CCI Europe, Vienna, Austria., Degelsegger A; Gesundheit Österreich GMBH, Vienna, Austria., Düster V; St. Anna Children's Cancer Research Institute, Vienna, Austria., Filbert AL; University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Grabow D; University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Gredinger G; Gesundheit Österreich GMBH, Vienna, Austria., Gsell H; CCI Europe, Vienna, Austria., Haupt R; IRCCS Istituto Giannina Gaslini, Genova, Italy., van Helvoirt M; University Hospitals Leuven, KU, Louvain, Belgium., Ladenstein R; St. Anna Children's Hospital, Vienna, Austria.; St. Anna Children's Cancer Research Institute, Vienna, Austria., Langer T; Universitatsklinikum Schleswig-Holstein, Campus Lubeck, Lubeck, Germany., Laschkolnig A; Gesundheit Österreich GMBH, Vienna, Austria., Muraca M; IRCCS Istituto Giannina Gaslini, Genova, Italy., Rascon J; Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania., Schreier G; AIT Austrian Institute of Technology, Graz, Austria., Tomasikova Z; CCI Europe, Vienna, Austria., Tormo MT; Instituto Investigación Sanitaria La Fe, Valencia, Spain., Trinkunas J; Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania., Trollip J; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands., Trunner K; Gesundheit Österreich GMBH, Vienna, Austria., Uyttebroeck A; Universitatsklinikum Schleswig-Holstein, Campus Lubeck, Lubeck, Germany., van der Pal HJH; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands., Pluijm SMF; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.
Publikováno v:
Journal of cancer survivorship : research and practice [J Cancer Surviv] 2024 Jun; Vol. 18 (3), pp. 928-940. Date of Electronic Publication: 2023 Feb 20.
Autor:
de Beijer IAE; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., van den Oever SR; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Charalambous E; Health Level Seven Europe, Brussels, Belgium.; Venizeleio General Hospital of Heraklion, Heraklion, Greece., Cangioli G; Health Level Seven Europe, Brussels, Belgium., Balaguer J; Hospital Universitario y Politécnico La Fe, Valencia, Spain., Bardi E; St Anna Children's Hospital, Vienna, Austria.; Department of Paediatrics and Adolescent Medicine, Kepler University Hospital, Johannes Kepler University Linz, Linz, Austria., Alfes M; Childhood Cancer International Europe, Vienna, Austria., Cañete Nieto A; Hospital Universitario y Politécnico La Fe, Valencia, Spain., Correcher M; Instituto Investigación Sanitaria La Fe, Valencia, Spain., Pinto da Costa T; Childhood Cancer International Europe, Vienna, Austria., Degelsegger-Márquez A; Gesundheit Österreich GmbH, Vienna, Austria., Düster V; Department of Studies and Statistics for Integrated Research and Projects, St Anna Children's Cancer Research Institute, Vienna, Austria., Filbert AL; Division of Childhood Cancer Epidemiology, German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Grabow D; Division of Childhood Cancer Epidemiology, German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Gredinger G; Gesundheit Österreich GmbH, Vienna, Austria., Gsell H; Childhood Cancer International Europe, Vienna, Austria., Haupt R; Diagnosi, Osservazione, Prevenzione dopo trattamento Oncologico Clinic, Department of Hematology/Oncology, Istituto di Ricovero e Cura a Carattere Scientifico Istituto Giannina Gaslini, Genova, Italy., van Helvoirt M; University Hospitals Leuven, Katholieke Universiteit Leuven, Leuven, Belgium., Ladenstein R; St Anna Children's Hospital, Vienna, Austria.; Department of Studies and Statistics for Integrated Research and Projects, St Anna Children's Cancer Research Institute, Vienna, Austria.; Department of Paediatrics, Medical University of Vienna, Vienna, Austria., Langer T; Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Lübeck, Germany., Laschkolnig A; Gesundheit Österreich GmbH, Vienna, Austria., Muraca M; Diagnosi, Osservazione, Prevenzione dopo trattamento Oncologico Clinic, Department of Hematology/Oncology, Istituto di Ricovero e Cura a Carattere Scientifico Istituto Giannina Gaslini, Genova, Italy., Pluijm SMF; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Rascon J; Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.; Clinics for Children's Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania., Schreier G; Center for Health and Bioresources, Austrian Institute of Technology, Graz, Austria., Tomášikova Z; Childhood Cancer International Europe, Vienna, Austria., Trauner F; Gesundheit Österreich GmbH, Vienna, Austria., Trinkūnas J; Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania., Trunner K; Gesundheit Österreich GmbH, Vienna, Austria., Uyttebroeck A; University Hospitals Leuven, Katholieke Universiteit Leuven, Leuven, Belgium., Kremer LCM; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands.; Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands., van der Pal HJH; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Chronaki C; Health Level Seven Europe, Brussels, Belgium.
Publikováno v:
Journal of medical Internet research [J Med Internet Res] 2024 May 02; Vol. 26, pp. e49910. Date of Electronic Publication: 2024 May 02.
Autor:
Filbert AL; Division of Childhood Cancer Epidemiology, German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Kremer L; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Ladenstein R; St. Anna Children's Cancer Research Institute, Vienna, Austria; St Anna Children's Hospital, Vienna, Austria., Chronaki C; HL7 Europe, Brussels, Belgium., Degelsegger-Márquez A; Gesundheit Österreich GmbH, Vienna, Austria., van der Pal H; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Bardi E; St Anna Children's Hospital, Vienna, Austria; Department of Paediatrics and Adolescent Medicine, Johannes Kepler University Linz, Kepler University Hospital, Linz, Austria., Uyttebroeck A; University Hospitals Leuven, KU Leuven, Belgium., Langer T; Universitatsklinikum Schleswig-Holstein, Campus Lubeck, Germany., Muraca M; IRCCS Istituto Giannina Gaslini, Genova, Italy., Nieto AC; Hospital Universitario y Politécnico La Fe, Valencia, Spain., Rascon J; Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania; Clinics for Children's Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Lithuania., Bagnasco F; IRCCS Istituto Giannina Gaslini, Genova, Italy., Beyer S; AIT Austrian Institute of Technology, Graz, Austria., Te Dorsthorst J; PanCare, Bussum, the Netherlands., Essiaf S; SIOP Europe, Brussels, Belgium., Galan AO; Instituto Investigación Sanitaria La Fe, Valencia, Spain., Kienesberger A; CCI Europe, Vienna, Austria., O'Brien K; Pintail, Dublin, Ireland., Palau MC; Instituto Investigación Sanitaria La Fe, Valencia, Spain., Pluijm SMF; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., di Profio S; Clinical Psychology Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy., Saraceno D; CINECA Interuniversity Consortium, Italy., Schneider C; CCI Europe, Vienna, Austria., Schreier G; AIT Austrian Institute of Technology, Graz, Austria., Trinkūnas J; Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania., Zamberlan I; Liguria Digitale S.p.A., Italy., Grabow D; Division of Childhood Cancer Epidemiology, German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany. Electronic address: desiree.grabow@uni-mainz.de., Haupt R; IRCCS Istituto Giannina Gaslini, Genova, Italy.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 May; Vol. 202, pp. 114029. Date of Electronic Publication: 2024 Mar 19.